Table 5.

Effects of non-fungal intra-amniotic infection, intra-amniotic inflammation, and an intrauterine contraceptive device (IUD) on the specificity of the beta- glucan assay.

Patients	Total (n)	Negative assay (n)	Specificity
Overall	177	133	75.1%
Women with an IUD	49	16	32.7%
Women without an IUD	128	117	91.4%
No IUD, no intra-amniotic infection	114	106	93.0%
No IUD, non-fungal intra-amniotic infection	14	11	78.6%
No IUD, no intra-amniotic infection, no intra-amniotic inflammation	90	85	94.4%
No IUD, no inflammation, non-fungal intra-amniotic infection	6	5	83.3%
No IUD, no intra-amniotic infection, no intra-amniotic inflammation	24	21	87.5%
No IUD, non-fungal-intra-amniotic infection, intra-amniotic inflammation	8	6	75.0%
IUD, no intra-amniotic infection	28	7	25.0%
IUD, non-fungal intra-amniotic infection	21	9	42.9%
IUD, no intra-amniotic infection, no intra-amniotic inflammation	12	4	33.3%
IUD, no intra-amniotic infection, intra-amniotic inflammation	16	3	18.8%
IUD, non-fungal intra-amniotic infection, intra-amniotic inflammation	21	9	42.9%

LEGEND. n: number.